Monday, Vanda Pharmaceuticals Inc. (VNDA) said its third-quarter net loss narrowed to $7.72 million from $10.86 million in the prior year period.
Net loss per share attributable to common stockholders for the quarter also narrowed to $0.28 from $0.41 in the year-ago period. On average, 2 analysts polled by Thomson Reuters expected the company to report a loss of $0.31 per share for the quarter.
For comments and feedback: editorial@rttnews.com